159 related articles for article (PubMed ID: 38172220)
21. Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
Satomaa T; Heiskanen A; Leonardsson I; Angström J; Olonen A; Blomqvist M; Salovuori N; Haglund C; Teneberg S; Natunen J; Carpén O; Saarinen J
Cancer Res; 2009 Jul; 69(14):5811-9. PubMed ID: 19584298
[TBL] [Abstract][Full Text] [Related]
22. Differential
Yaman ME; Kayili HM; Albayrak M; Kadioglu Y; Salih B
Mol Omics; 2021 Jun; 17(3):394-404. PubMed ID: 33735360
[TBL] [Abstract][Full Text] [Related]
23. Altered N-linked glycosylation in endometrial cancer.
Mittal P; Briggs M; Klingler-Hoffmann M; Kaur G; Packer NH; Oehler MK; Hoffmann P
Anal Bioanal Chem; 2021 Apr; 413(10):2721-2733. PubMed ID: 33222001
[TBL] [Abstract][Full Text] [Related]
24. N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.
Balog CI; Stavenhagen K; Fung WL; Koeleman CA; McDonnell LA; Verhoeven A; Mesker WE; Tollenaar RA; Deelder AM; Wuhrer M
Mol Cell Proteomics; 2012 Sep; 11(9):571-85. PubMed ID: 22573871
[TBL] [Abstract][Full Text] [Related]
25. High-mannose glycans are elevated during breast cancer progression.
de Leoz ML; Young LJ; An HJ; Kronewitter SR; Kim J; Miyamoto S; Borowsky AD; Chew HK; Lebrilla CB
Mol Cell Proteomics; 2011 Jan; 10(1):M110.002717. PubMed ID: 21097542
[TBL] [Abstract][Full Text] [Related]
26. Enhanced Detection of Charged
Samal J; Palomino TV; Chen J; Muddiman DC; Segura T
Anal Chem; 2023 Jul; 95(29):10913-10920. PubMed ID: 37427925
[No Abstract] [Full Text] [Related]
27. Identification of phosphorylation sites in N-linked glycans by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Takashiba M; Chiba Y; Jigami Y
Anal Chem; 2006 Jul; 78(14):5208-13. PubMed ID: 16841950
[TBL] [Abstract][Full Text] [Related]
28. N-glycomic profiling of colorectal cancer according to tumor stage and location.
Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C
PLoS One; 2020; 15(6):e0234989. PubMed ID: 32598367
[TBL] [Abstract][Full Text] [Related]
29. N-Glycome changes reflecting resistance to platinum-based chemotherapy in ovarian cancer.
Zahradnikova M; Ihnatova I; Lattova E; Uhrik L; Stuchlikova E; Nenutil R; Valik D; Nalezinska M; Chovanec J; Zdrahal Z; Vojtesek B; Hernychova L; Novotny MV
J Proteomics; 2021 Jan; 230():103964. PubMed ID: 32898699
[TBL] [Abstract][Full Text] [Related]
30. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.
Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F
J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294
[TBL] [Abstract][Full Text] [Related]
31. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.
Drake RR; Powers TW; Jones EE; Bruner E; Mehta AS; Angel PM
Adv Cancer Res; 2017; 134():85-116. PubMed ID: 28110657
[TBL] [Abstract][Full Text] [Related]
32. High-throughput quantitative analysis of total N-glycans by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Jeong HJ; Kim YG; Yang YH; Kim BG
Anal Chem; 2012 Apr; 84(7):3453-60. PubMed ID: 22455307
[TBL] [Abstract][Full Text] [Related]
33. Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.
Zhao S; Ma D; Xiao Y; Li XM; Ma JL; Zhang H; Xu XL; Lv H; Jiang WH; Yang WT; Jiang YZ; Zhang QY; Shao ZM
Oncologist; 2020 Oct; 25(10):e1481-e1491. PubMed ID: 32406563
[TBL] [Abstract][Full Text] [Related]
34. N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.
Alley WR; Vasseur JA; Goetz JA; Svoboda M; Mann BF; Matei DE; Menning N; Hussein A; Mechref Y; Novotny MV
J Proteome Res; 2012 Apr; 11(4):2282-300. PubMed ID: 22304416
[TBL] [Abstract][Full Text] [Related]
35. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
36. Altered glycosylation of alpha1-acid glycoprotein in patients with inflammation and diabetes mellitus.
Higai K; Azuma Y; Aoki Y; Matsumoto K
Clin Chim Acta; 2003 Mar; 329(1-2):117-25. PubMed ID: 12589974
[TBL] [Abstract][Full Text] [Related]
37. Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans.
Zhang Y; Wang B; Jin W; Wen Y; Nan L; Yang M; Liu R; Zhu Y; Wang C; Huang L; Song X; Wang Z
Anal Chim Acta; 2019 Feb; 1048():105-114. PubMed ID: 30598139
[TBL] [Abstract][Full Text] [Related]
38. Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients.
Hanzawa K; Tanaka-Okamoto M; Murakami H; Suzuki N; Mukai M; Takahashi H; Omori T; Ikezawa K; Ohkawa K; Ohue M; Natsuka S; Miyamoto Y
PLoS One; 2022; 17(4):e0266927. PubMed ID: 35413075
[TBL] [Abstract][Full Text] [Related]
39. Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry.
Ritchie G; Harvey DJ; Stroeher U; Feldmann F; Feldmann H; Wahl-Jensen V; Royle L; Dwek RA; Rudd PM
Rapid Commun Mass Spectrom; 2010 Mar; 24(5):571-85. PubMed ID: 20131323
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
Lee SB; Bose S; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Lee K; Chang S; Park HS; Lee JW; Kim DC
PLoS One; 2020; 15(4):e0231004. PubMed ID: 32271809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
